The biopharmaceutical industry contributes to the development of Latin America and the Caribbean both through our societal impact, developing products that help people lead healthier and more productive lives, and through our economic footprint in the countries where we operate.
The innovative medicines produced by the biopharmaceutical industry enable a healthier population and a more resilient health system, contributing to the overall development of the region.
As part of the healthcare industry, we hold ourselves to the highest ethical standards. We owe it to patients who rely on our medicines and vaccines. That is why our members adhere to the strictest guidelines and criteria and work to continuously raise the bar on operations and transparency across the industry for the benefit of patients and health systems in the region.
Multi-stakeholder engagement and collaboration can help to make health systems more patient-centric and contribute to the achievement of common objectives. FIFARMA partners with stakeholders including patient advocacy organizations, academia, government, professional organizations (including medical societies) and multilateral organizations to support public policy research and raise public awareness on important health issues in order to improve patient care and business practices in the region.
Subscribe to our newsletter and receive relevant news about our industry and region.
